CLINICAL_TRIALS
trial_result
· 2018-06-04
Clinical Trial Update: A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver [Phase 2]
Summary
Phase 2 study of IMC-A12 plus sorafenib in hepatocellular carcinoma completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-04